2023
McGuff Medical secures and develops its new, state-of-the-art warehouse and corporate office.
If you can't find what you were looking for, please contact us using one of the methods below so we can better serve you.
McGuff Medical secures and develops its new, state-of-the-art warehouse and corporate office.
McGuff Compounding Pharmacy Services, Inc. (503A) rebrands and submits for licensing as a 503B outsourcing facility - McGuff Outsourcing Solutions (MOS).
McGuff celebrates 50 years as a family and veteran-owned company.
Saving Glutathione! McGuff, along with the assistance of other nominators, was able to convince the Pharmacy Compounding Advisory Committee (put in place by the FDA) to keep Glutathione as a bulk drug substance able to compound.
McGuff Pharmaceuticals, Inc. expands into an 86,000-square-foot facility.
ASCOR® (Ascorbic Acid Injection, USP) NDA was approved by the FDA - 11 years in the making! McGuff Pharmaceuticals, Inc. received the FDA’s sole approval for vitamin C injection guaranteeing its availability to the United States market.
McGuff organized a petition with customers to persuade Congress to reduce rigid regulations that were limiting the ability of compounding pharmacies to supply patients with their medications in a timely manner.
McGuff receives approval for Hydroxyprogesterone Caproate injection, an equivalent to Delalutin Injection.
McGuff Medical Canada, Inc. was formed to supply pharmaceutical drugs to the Canadian market.
McGuff Pharmaceuticals, Inc. submitted an NDA application for ASCOR® (Ascorbic Acid Injection, USP).
McGuff launched McGuff Pharmaceuticals, Inc. to produce injectable pharmaceuticals.
McGuff established McGuff Compounding Pharmacy Services, Inc. (503A compounding pharmacy).
McGuff Medical expands from a home-based business to a larger corporate location.
Gil McGuff sold McGuff Company, Inc. to his youngest son, Ronald McGuff (current President and CEO) and was hired as its first official employee.
Gilbert McGuff originally established McGuff Company, Inc. as a sole proprietor for a side job. He supplied bariatric physicians and patients with innovative medical products.
Due to the Coronavirus (COVID-19) outbreak worldwide, the global demand for some Personal Protective Equipment (PPE) is exceeding current supply availability.
In addition, the manufacturing of the PPE and many other wound care/infection prevention products have been impacted by the global response to the Coronavirus. While you may see product availability reduction in the near-term, please be assured that we at McGuff Medical are continuing to work diligently to ensure an uninterrupted supply of products and alternative products to you.
Additionally, in order to ensure healthcare providers have access to the PPEs they need, the McGuff Company is temporarily limiting PPEs to healthcare providers.
As always, please feel free to reach out to our McGuff Customer Service team with any questions that you may have.